SCHEMBL77753

SCHEMBL77753

C[CH]CC(C)CCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1005858 0.92 OPRM1 (0.44)
SCHEMBL9626011 0.90 ACE2 (0.45)
SCHEMBL5684181 0.90 ACE2 (0.45)
SCHEMBL26632352 0.90 ACE2 (0.45)
SCHEMBL5684301 0.90 ACE2 (0.45)
SCHEMBL5686908 0.90 ACE2 (0.45)
SCHEMBL4458439 0.90 ACE2 (0.45)
SCHEMBL5686549 0.90 ACE2 (0.45)
SCHEMBL9212678 0.90 ACE2 (0.45)
SCHEMBL28271633 0.90 ACE2 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 636 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10202322-B2 Resorcinol derivatives SUTTER BAY HOSPITALS (US) 2019-02-12 US claimed
US-20180170846-A1 RESORCINOL DERIVATIVES SUTTER WEST BAY HOSPITALS 2018-06-21 US claimed
EP-2433937-B1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof PURDUE PHARMA LP (US) 2016-06-29 EP claimed
EP-2086958-B1 SUBSTITUTED-QUINOXALINE-TYPE-PIPERIDINE COMPOUNDS AND THE USES THEREOF PURDUE PHARMA LP (US) 2015-01-14 EP claimed
CN-101878208-B Substituted-quinoxaline-type-piperidine compounds and the uses thereof PURDUE PHARMA L.P. (US) 2014-10-15 CN claimed
US-20130209483-A1 CANNABIDINOID DERIVATIVES SUTTER WEST BAY HOSPITALS (US) 2013-08-15 US claimed
JP-10109957-A None JP disclosed
CN-114364405-B Prostate Specific Membrane Antigen (PSMA) inhibitors as diagnostic and radionuclide therapeutics 五一一制药股份有限公司 2024-07-16 CN disclosed
WO-2024147345-A1 COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, NEGATIVE ELECTRODE FOR LITHIUM ION BATTERIES, LITHIUM ION BATTERY, AND METHOD FOR PRODUCING COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES APB株式会社 2024-07-11 WO disclosed
WO-2024140700-A1 BENZOTHIAZOLE COMPOUND, AND SYNTHESIS THEREFOR AND USE THEREOF 西北农林科技大学 2024-07-04 WO disclosed
WO-2024121253-A1 NOVEL N,N-DIMETHYLTRYPTAMINE (DMT) DERIVATIVES AND USES THEREOF MIHKAL GMBH (CH) 2024-06-13 WO disclosed
CN-117580842-A Compound, composition for anisotropic dye film comprising same, anisotropic dye film, and optical element 三菱化学株式会社 2024-02-20 CN disclosed
EP-4112053-B1 TREATMENT OF SYNUCLEINOPATHIES DEUTSCHES ZENTRUM FUER NEURODEGENERATIVE ERKRANKUNGEN E V DZNE (DE) 2024-02-14 EP disclosed
JP-H10109957-A LIQUID CRYSTAL COMPOUND CAPABLE OF CONTROLLING SPONTANEOUS POLARIZATION BY CONFIGURATION OF DIASTEREOMER, ITS INTERMEDIATE, AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME COMPOUND SHOWA SHELL SEKIYU KK 1998-04-28 JP disclosed
US-5385693-A Having rapid response and low phase transition temperature SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-01-31 US disclosed
EP-0357372-B1 Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element SUMITOMO CHEMICAL CO (JP) 1994-11-17 EP disclosed
US-5264151-A Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-11-23 US disclosed
US-5124070-A High speed response SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1992-06-23 US disclosed
EP-0357372-A2 Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-03-07 EP disclosed
EP-0176161-A1 Novel fluoran compounds and production and use thereof TAOKA CHEMICAL CO., LTD (JP) 1986-04-02 EP disclosed